D. Geller and R. Gorlick, Osteosarcoma: a review of diagnosis, management, and treatment strategies, Clin Adv Hematol Oncol, vol.8, pp.705-718, 2010.

N. Marina, M. Gebhardt, L. Teot, and R. Gorlick, Biology and Therapeutic Advances for Pediatric Osteosarcoma, The Oncologist, vol.9, issue.4, pp.422-441, 2004.
DOI : 10.1634/theoncologist.9-4-422

URL : http://theoncologist.alphamedpress.org/content/9/4/422.full.pdf

B. Wadayama, J. Toguchida, T. Shimizu, K. Ishizaki, M. Sasaki et al., Mutation spectrum of the retinoblastoma gene in osteosarcomas, Cancer Res, vol.54, pp.3042-3048, 1994.

A. Sandberg and J. Bridge, Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors, Cancer Genetics and Cytogenetics, vol.145, issue.1, pp.1-30, 2003.
DOI : 10.1016/S0165-4608(03)00105-5

M. Bernstein, H. Kovar, M. Paulussen, R. Randall, A. Schuck et al., Ewing's Sarcoma Family of Tumors: Current Management, The Oncologist, vol.11, issue.5, pp.503-519, 2006.
DOI : 10.1634/theoncologist.11-5-503

J. Ewing, Diffuse Endothelioma of Bone, Proceedings of the New York Pathological Society, pp.95-98, 1921.
DOI : 10.3322/canjclin.22.2.95

N. Riggi, L. Cironi, P. Provero, M. Suva, K. Kaloulis et al., Development of Ewing's Sarcoma from Primary Bone Marrow???Derived Mesenchymal Progenitor Cells, Cancer Research, vol.65, issue.24, pp.11459-11468, 2005.
DOI : 10.1158/0008-5472.CAN-05-1696

J. Kim and J. Pelletier, and related family members, Physiological Genomics, vol.1, issue.3, pp.127-138, 1999.
DOI : 10.1101/gad.8.21.2513

H. Komuro, Y. Hayashi, M. Kawamura, K. Hayashi, Y. Kaneko et al., Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas, Cancer Res, vol.53, pp.5284-5288, 1993.

D. Liebner, The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma, Journal of Surgical Oncology, vol.70, issue.5, pp.622-631, 2015.
DOI : 10.1007/s00280-012-1968-x

T. Ozaki, H. Sugimoto, M. Nakamura, K. Hiraoka, H. Yoda et al., Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity, FEBS Journal, vol.20, issue.1, pp.114-128, 2015.
DOI : 10.1038/sj.onc.1204149

N. Ibrahim, L. He, C. Leong, D. Xing, B. Karlan et al., BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma, Cancer Research, vol.70, issue.18, pp.7155-7165, 2010.
DOI : 10.1158/0008-5472.CAN-10-0668

K. Liu, X. Zhuang, and Z. Mai, p73 expression is associated with cellular chemosensitivity in human non-small cell lung cancer cell lines, Oncology Letters, vol.5, issue.2, pp.583-587, 2013.
DOI : 10.3892/ol.2012.1035

K. Tomkova, M. Tomka, and V. Zajac, Contribution of p53, p63, and p73 to the developmental diseases and cancer, Neoplasma, vol.55, pp.177-181, 2008.

K. Inoue and E. Fry, Alterations of p63 and p73 in Human Cancers, Subcell Biochem, vol.85, pp.17-40, 2014.
DOI : 10.1007/978-94-017-9211-0_2

A. Mills, B. Zheng, X. Wang, H. Vogel, D. Roop et al., p63 is a p53 homologue required for limb and epidermal morphogenesis, Nature, vol.10, issue.6729, pp.708-713, 1999.
DOI : 10.1006/geno.1998.5423

G. Fontemaggi, I. Kela, N. Amariglio, G. Rechavi, J. Krishnamurthy et al., Identification of Direct p73 Target Genes Combining DNA Microarray and Chromatin Immunoprecipitation Analyses, Journal of Biological Chemistry, vol.114, issue.45, pp.43359-43368, 2002.
DOI : 10.1006/mcbr.2001.0301

A. Zaika, N. Slade, S. Erster, C. Sansome, T. Joseph et al., DeltaNp73, a dominantnegative inhibitor of wild-type p53 and TAp73, is upregulated in human tumors Infrequent somatic mutations of the p73 gene in various human cancers, J Exp Med. Eur J Surg Oncol, vol.196, issue.25, pp.765-780194, 1999.

U. Moll and N. Slade, p63 and p73: roles in development and tumor formation. Molecular cancer research, pp.371-386, 2004.

X. Hu, N. Wu, P. Xia, S. Yu, F. Sun et al., Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells, Cancer Chemotherapy and Pharmacology, vol.9, issue.5, pp.1205-1212, 2012.
DOI : 10.4161/cc.9.4.10668

B. Ory, M. Ramsey, C. Wilson, D. Vadysirisack, N. Forster et al., A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma, Journal of Clinical Investigation, vol.121, issue.2, pp.809-820, 2011.
DOI : 10.1172/JCI43897DS1

D. Bartel, MicroRNAs, Cell, vol.116, issue.2, pp.281-297, 2004.
DOI : 10.1016/S0092-8674(04)00045-5

URL : https://hal.archives-ouvertes.fr/hal-00369966

W. Filipowicz, S. Bhattacharyya, and N. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nature Reviews Genetics, vol.131, issue.2, pp.102-114, 2008.
DOI : 10.1038/ncb1333

R. Lee, R. Feinbaum, and A. V. , The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, vol.75, issue.5, pp.843-854, 1993.
DOI : 10.1016/0092-8674(93)90529-Y

URL : https://hal.archives-ouvertes.fr/in2p3-00597159

R. Garzon, G. Marcucci, and C. Croce, Targeting microRNAs in cancer: rationale, strategies and challenges, Nature Reviews Drug Discovery, vol.124, issue.10, pp.775-789, 2010.
DOI : 10.4161/cc.7.16.6533

G. Melino, F. Bernassola, M. Ranalli, K. Yee, W. Zong et al., p73 Induces Apoptosis via PUMA Transactivation and Bax Mitochondrial Translocation, Journal of Biological Chemistry, vol.62, issue.9, pp.8076-8083, 2004.
DOI : 10.1016/S1535-6108(02)00064-8

URL : http://www.jbc.org/content/279/9/8076.full.pdf

R. Kommagani, A. Whitlatch, M. Leonard, and M. Kadakia, p73 is essential for vitamin D-mediated osteoblastic differentiation, Cell Death & Differentiation, vol.44, issue.9, pp.398-407, 2010.
DOI : 10.2106/00004623-199173090-00022

W. Liang, H. Xia, J. Li, C. Zhao, and R. , 5-aza-2???-deoxycytidine Increases the Sensitivity of Human Bone Marrow Mesenchymal Stem Cells to Chemotherapeutic Agents by Demethylation of p73, Journal of Pediatric Hematology/Oncology, vol.34, issue.2, pp.108-115, 2012.
DOI : 10.1097/MPH.0b013e31823e0a87

C. Tophkhane, S. Yang, Y. Jiang, Z. Ma, D. Subramaniam et al., p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription, PLoS ONE, vol.7, issue.8, p.43564, 2012.
DOI : 10.1371/journal.pone.0043564.g006

Z. Zhang, H. Zhang, Y. Kang, P. Sheng, Y. Ma et al., miRNA expression profile during osteogenic differentiation of human adipose-derived stem cells, Journal of Cellular Biochemistry, vol.7, issue.2, pp.888-898, 2012.
DOI : 10.1089/107632701300062859

H. Hu, Y. Zhang, X. Cai, J. Huang, and L. Cai, Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts, Oncology Letters, vol.4, issue.5, pp.1037-1042, 2012.
DOI : 10.3892/ol.2012.866

M. Agostini, M. Niklison-chirou, M. Catani, R. Knight, G. Melino et al., TAp73 promotes anti-senescence-anabolism not proliferation, Aging, vol.6, issue.11, pp.921-930, 2014.
DOI : 10.18632/aging.100701

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276786/pdf

K. Furuya, T. Ozaki, T. Hanamoto, M. Hosoda, S. Hayashi et al., Stabilization of p73 by Nuclear I??B Kinase-?? Mediates Cisplatin-induced Apoptosis, Journal of Biological Chemistry, vol.143, issue.25, pp.18365-18378, 2007.
DOI : 10.1038/sj.cdd.4400631

C. Leong, N. Vidnovic, M. Deyoung, D. Sgroi, and L. Ellisen, The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers, Journal of Clinical Investigation, vol.117, issue.5, pp.1370-1380, 2007.
DOI : 10.1172/JCI30866

M. Liu, X. Zhang, C. Hu, Q. Xu, H. Zhu et al., MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells, Chinese Journal of Cancer, vol.33, issue.6, pp.285-294, 2014.
DOI : 10.5732/cjc.013.10136

D. Ovcharenko, K. Kelnar, C. Johnson, N. Leng, and D. Brown, Genome-Scale MicroRNA and Small Interfering RNA Screens Identify Small RNA Modulators of TRAIL-Induced Apoptosis Pathway, Cancer Research, vol.67, issue.22, pp.10782-10788, 2007.
DOI : 10.1158/0008-5472.CAN-07-1484